Table 1 Patients’ characteristics
Characteristics | LEUKOFRANCE CCALD cohort (N = 52) | |
|---|---|---|
Age (y) | median (Q1-Q3) | 7.0 (6.0–9.0) |
min-max | 0.5–13.0 | |
Age classes (y) | ||
< 3 years old | N (%) | 2 (3.8) |
[3–5[ years old | 2 (3.8) | |
[5–8[ years old | 27 (51.9) | |
[8–12[ years old | 17 (32.7) | |
[12–15[ years old | 4 (7.7) | |
[15–18[ years old | 0 (0.0) | |
ALD family history | ||
yes | N (%) | 15 (29.4) |
no | 36 (70.6) | |
Incident cases | ||
2009 | N | 2 |
2010 | 3 | |
2011 | 5 | |
2012 | 2 | |
2013 | 4 | |
2014 | 2 | |
2015 | 6 | |
2016 | 3 | |
2017 | 4 | |
2018 | 4 | |
10-year study period | N (%) | 35 (67.3) |
Prevalent cases | N (%) | 17 (32.7) |
Inclusion status | ||
Familial screen cases | N (%) | 14 (26.9) |
Index cases | N (%) | 38 (73.1) |
Hematopoietic stem cell transplant (HSCT) status | ||
Patients with allogenic HSCT | N (%) | 19 (36.5) |
Patients without allogenic HSCT | N (%) | 29 (55.8) |
Patients with gene and auto HSCT therapy | N (%) | 3 (5.8) |
Missing value | N (%) | 1 (1.9) |